Going Public: When will Take-off Point be Reached?

  • Stephanie Jones


‘In 1983, Biogen made its first initial public offering, at the same time as Amgen, Applied Biosystems, and Chiron. Two years later, in 1985, out of the blue, the Biogen board contacted me and asked me if I’d come up here and run Biogen, and I’ve been doing just that, having taken over from Professor Walter Gilbert. Biogen was in a very serious financial condition, and it was clearly going bust. It was losing about $30m a year and it was running out of cash. As Business Week reported, “The company was sliding deeper into the red as its scientists pursued 15 diverse projects ranging from cancer drugs to nickel extraction.”


Venture Capitalist Initial Public Offering Agricultural Biotechnology Biotech Company Genetic Institute 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© International Business Writing Limited 1992

Authors and Affiliations

  • Stephanie Jones

There are no affiliations available

Personalised recommendations